Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »

For full access to this article login to GEN Select now.

October 15, 2014 (Vol. 34, No. 18)

Exceptional Responders: The “N of 1” Paradigm

Hope for Better Cancer Treatments May Lie in Those Patients Who Respond Exceptionally Well

  • We have all heard stories about the single patient who survives a deadly cancer in response to a particular drug, in contrast to other patients receiving the same drug who succumb to the disease. These patients may include heavily pretreated cancer patients for whom other drugs have failed, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.